N-[(5-chlorothiophen-2-yl)methyl]-5-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-1H-pyrazol-3-amine
C19H28ClN5OS — CID 122508899
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(5-chlorothiophen-2-yl)methyl]-5-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-1H-pyrazol-3-amine
N-[(5-chlorothiophen-2-yl)methyl]-5-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-1H-pyrazol-3-amine (PubChem CID 122508899) has the molecular formula C19H28ClN5OS and a molecular weight of 409.99 g/mol. Its IUPAC name is N-[(5-chlorothiophen-2-yl)methyl]-5-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-1H-pyrazol-3-amine.
Molecular Properties
| Compound Name | N-[(5-chlorothiophen-2-yl)methyl]-5-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-1H-pyrazol-3-amine |
|---|---|
| PubChem CID | 122508899 |
| Molecular Formula | C19H28ClN5OS |
| Molecular Weight | 409.99 g/mol |
| Exact Mass | 409.17 |
| IUPAC Name | N-[(5-chlorothiophen-2-yl)methyl]-5-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-1H-pyrazol-3-amine |
| SMILES | Clc1ccc(CNc2cc(C3CCN(CCN4CCOCC4)CC3)[nH]n2)s1 |
| InChI | InChI=1S/C19H28ClN5OS/c20-18-2-1-16(27-18)14-21-19-13-17(22-23-19)15-3-5-24(6-4-15)7-8-25-9-11-26-12-10-25/h1-2,13,15H,3-12,14H2,(H2,21,22,23) |
| InChIKey | ALEFKJQNFHSOSM-UHFFFAOYSA-N |
| XLogP | 3.25 |
| TPSA | 56.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.99 |
| LogP ≤ 5 | 3.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122508899 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.